Suzanne Greco, an accomplished finance professional with 20 years of experience in the biotech industry, has been the Vice President of Finance at Repertoire since August 2021. Suzanne is responsible for overseeing strategic financial planning and modeling, control, compliance, tax and treasury activities as well as finance operations at the Company.

Prior to Repertoire, Suzanne spent three years at Sanofi as an Investor Relations Officer where she led communication development for investor events and represented Sanofi at conferences and roadshows. Suzanne joined Sanofi, following Sanofi’s acquisition of Bioverativ, where Suzanne was the Head of the Financial Planning & Analysis Team and led the valuation analyses, board/management presentation development and financial due diligence for the $11.6B acquisition as well as oversaw the financial modeling of the $825M acquisition of clinical-stage company, Ture North Therapeutics. Prior to Bioverativ, Suzanne spent 12 years at Biogen in numerous roles of increasing responsibility providing company executives as well as R&D and Commercial leadership teams with financial insights to make thoughtful, analytically-based decisions.

Suzanne received her Master of Business Administration degree from the Tuck School of Business at Dartmouth and graduated summa cum laude from the State University of New York at Binghamton with a Bachelor of Science degree in Accounting. Suzanne is also a licensed Certified Public Accountant in the State of New York.